Home
http://www.virbac.fr/ http://www.boehringer-ingelheim.com/ http://www.novartis.com/ http://www.animalhealth.bayerhealthcare.com/
vetcontact
Vetrinär
Tiermedizin
  WELCOME  
vetcontact
Vetrinär
Tiermedizin
  Home  
  Login / Newsletter  
vetcontact
Vetrinär
Tiermedizin
  CONTACTS  
vetcontact
Vetrinär
Tiermedizin
  Classifieds  
  New Products  
  VetCompanies  
  VetSchools  
vetcontact
Vetrinär
Tiermedizin
  PROFESSION  
vetcontact
Vetrinär
Tiermedizin
  Edutainment  
  VetAgenda  
  Presentations  
  Posters  
  ESAVS  
  Specialisation  
vetcontact
Vetrinär
Tiermedizin
  INSIGHT  
vetcontact
Vetrinär
Tiermedizin
  Congress News  
  Picture Galleries  
vetcontact
Vetrinär
Tiermedizin
  PRODUCTS  
vetcontact
Vetrinär
Tiermedizin
  Bayer  
  Boehringer Ing.  
  Novartis  
  Virbac

 
  Simply book for less...  
    

Bovine    Equine    Small Animal Practice    Swine Practice    Articles    Vetjournal    
deutsch english español polski francais
Home / WELCOME / Archiv / Small Animal Practice /     
 
Intermediate steroid hormone levels in dogs with Alopecia X
Alopecia X remains a skin disease with an unclear pathogenesis. Evaluation of several hormon blood levels have been not very diagnostic in the past. This interesting study compares the interemdiate steroid levels before and during different therapies.

The purpose of the study was to evaluate intermediate adrenal steroid hormones (ISH) in neutered dogs with hair cycle arrest (Alopecia X) during treatment with melatonin, and to see if hair re-growth is associated with sex hormone concentrations within the normal ranges.

Twenty-nine neutered, euthyroid, and normo-cortisolemic dogs were enrolled in the study (23 Pomeranians, three keeshonds, two miniature poodles, and one Siberian husky).

Coat assessment and an ACTH stimulation test were performed pre-treatment and approximately every 4 months for a year post treatment.

Melatonin was administered initially at 3-6 mg, every 12 h. Based on clinical progression, each dog was continued on the current dose of melatonin, given an increased dose of melatonin or changed to mitotane.

Partial to complete hair re-growth occurred in 14/23 Pomeranians, and partial re-growth in 3/3 keeshond and 1/2 poodle dogs. A Siberian husky dog failed to re-grow hair. Fifteen dogs had partial hair re-growth at the first re-evaluation.

Melatonin dosage was increased in eight dogs but only one had improved hair re-growth.

On mitotane treatment, partial to complete hair re-growth was seen in 4/6 dogs and no re-growth in 2/6 dogs.

No significant decrease in sex hormone concentrations were seen during melatonin or mitotane treatment.

Concentrations of ISH in dogs with hair re-growth did not differ significantly from pre-treatment values. At the completion of the study, androstenedione, progesterone and 17-hydroxyprogesterone were still above reference ranges in 21, 64 and 36%, respectively, of dogs with partial to complete hair re-growth.

In conclusion, 62% of dogs had partial to complete hair re-growth. However, not all dogs with hair re-growth had concentrations of ISH within the normal range.


Source: Frank LA, Hnilica KA, Oliver JW. (2004):
Adrenal steroid hormone concentrations in dogs with hair cycle arrest (Alopecia X) before and during treatment with melatonin and mitotane. In: Vet Dermatol. 2004 Oct;15(5):278-84.




Tell a friend   |   Print version   |   Send this article

SMALL ANIMAL PRACTICE

Sedation and its effect on contrast-enhanced ultrasonography of the canine spleen
Contrast-enhanced ultrasound of the spleen enables the dynamic assessment of the perfusion of this organ, however, both subjective and quantitative evaluation can be strongly influenced by sedative agent administration. The purpose of this prospective, experimental study was to test effects of two sedative agents on splenic perfusion during contrast-enhanced ultrasound of the spleen in a sample of healthy dogs.

  • Overall hemostasis potential assay to identify dogs with thrombosis
  • Follow-up of 203 dogs with ventral midline gastropexy after GDVmembers
  • Atrial Fibrillation as Prognostic Indicator in Dogs with MMVD and CHFmembers
  • Adverse reactions to contrast media for diagnostic imaging in dogs and catsmembers
  • Cardiorespiratory parameters in pigeons undergoing isoflurane anaesthesia members
  • Orbital rhabdomyosarcoma in dogsmembers
  • Vinorelbine for dogs with primary urinary bladder carcinomamembers
  • Clinical spectrum and histologic correlation of canine indolent and aggressive lymphoma members
  • Grapiprant - an EP4 prostaglandin receptor antagonist members
  • Mode of inheritance and initial characterization of DEA-1members
  • Axial pattern skin flaps in dogs and cats - indications, complications, resultsmembers
  • Gallbladder mucocele and selected drugs in dogsmembers


  • [ Home ] [ About ] [ Contact / Request ][ Disclaimer ]

    Copyright © 2001-2015 VetContact GmbH
    All rights reserved